FIP1L1
Pre-mRNA 3'-end-processing factor FIP1
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 0.99 | ||
ligand (protein) perturbation | 0.96 | ||
transcription factor perturbation | 0.88 | ||
tissue | 0.69 | ||
virus perturbation | 0.68 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Gene expression (Transcription) | ||||
Reactome | Metabolism of RNA | ||||
Reactome | Processing of Capped Intron-Containing Pre-mRNA | ||||
Reactome | Processing of Capped Intronless Pre-mRNA | ||||
Reactome | Processing of Intronless Pre-mRNAs | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Gene expression (Transcription) | ||||
Metabolism of RNA | ||||
Processing of Capped Intron-Containing Pre-mRNA | ||||
Processing of Capped Intronless Pre-mRNA | ||||
Processing of Intronless Pre-mRNAs | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from High Throughput Direct Assay (HDA) | UniProtKB | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
heel bone mineral density | 2 | 1 | 2 | 72.3 | |||||
neutrophil count | 1 | 1 | 1 | 50.6 | |||||
1 | 1 | 0 | 2.2 | 36.9 | |||||
cervical artery dissection | 1 | 1 | 0 | 1.2 | 21.5 | ||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
heel bone mineral density | 2 | 72.3 | |||||
neutrophil count | 1 | 50.6 | |||||
0 | 2.2 | 36.9 | |||||
cervical artery dissection | 0 | 1.2 | 21.5 | ||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | factor interacting with PAPOLA and CPSF1 | VGNC:603 | 107974320 | |||||
Macaque | platelet derived growth factor receptor alpha [Source:HGNC Symbol;Acc:HGNC:8803] | |||||||
Mouse | MGI:1914149 | 66899 | ||||||
Rat | RGD:1309336 | 289582 | ||||||
Dog | factor interacting with PAPOLA and CPSF1 | VGNC:40883 | 612980 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | factor interacting with PAPOLA and CPSF1 | |||||
Macaque | platelet derived growth factor receptor alpha [Source:HGNC Symbol;Acc:HGNC:8803] | |||||
Mouse | ||||||
Rat | ||||||
Dog | factor interacting with PAPOLA and CPSF1 | |||||
PMID | Year | Title |
---|